Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2014
02/19/2014CN102978215B Paddy bacterial leaf streak resistance-related gene OsDRxoc6
02/19/2014CN102807609B Polypeptide for preventing and/or treating pain and application of polypeptide
02/19/2014CN102676544B Coding sequence of MYB family transcription factor gene OsMYB84 in rice and application of gene OsMYB84
02/19/2014CN102586286B Expression system of bacillus thur ingiens (Bt) insecticidal protein Cry1Ac-a
02/19/2014CN102584957B Specific antibody of Brucella specificity multi-epitope artificial polypeptide, immunomagnetic beads coated with specific bodies, and application of beads
02/19/2014CN102558312B New mutant protein of chronic viral hepatitis B related gene NLRX1, coding gene and application of coding gene
02/19/2014CN102558311B Mutant protein of chronic virus B hepatitis correlated gene TMEM2, coding gene of mutant protein and application of coding gene
02/19/2014CN102356089B Meningococcal fhbp polypeptides
02/19/2014CN101796069B Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
02/19/2014CN101273059B Alpha-MSH analogue of therapeutic activity
02/18/2014US8653344 Variety corn line NPFX7687
02/18/2014US8653327 Linear DNA molecule delivery using PEGylated quantum dots for stable transformation in plants
02/18/2014US8653239 Method for isolating polypeptides
02/18/2014US8653237 Peptide analogues
02/18/2014US8653032 Pharmaceutical composition for preventing / treating TRPV1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
02/18/2014US8653028 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
02/18/2014US8653024 Use of AMPs for treatment of UTI/cystitis
02/18/2014US8653020 Selective exosite inhibition of PAPP-A activity against IGFBP-4
02/18/2014US8652807 Lentiviral vectors for the preparation of immunotherapeutical compositions
02/18/2014US8652806 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
02/18/2014US8652514 Antimicrobial peptides
02/18/2014US8652473 Antibodies to EGF receptor epitope peptides and uses thereof
02/18/2014US8652457 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
02/18/2014CA2725100C Method for efficiently amplifying abnormal prion protein derived from bse
02/18/2014CA2708753C Peptide diagnostic agent for lyme disease
02/18/2014CA2674838C Anti-ige vaccines
02/18/2014CA2633468C Novel neurotrophic factor protein and uses thereof
02/18/2014CA2628342C Production and use of highly functional, highly branched or hyperbranched polylysines
02/18/2014CA2615249C Method to produce sterile male flowers and partenocarpic fruits by genetic silencing, associated sequences and vectors containing said sequences
02/18/2014CA2588594C Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
02/18/2014CA2585011C Chlamydia trachomatis antigens for vaccine and diagnostic use
02/18/2014CA2576627C Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
02/18/2014CA2574654C Compositions and methods of use for mgd-csf in disease treatment
02/18/2014CA2544820C Bacterial expression of protease inhibitors and variants thereof
02/18/2014CA2544467C Paralytic peptide for use in neuromuscular therapy
02/18/2014CA2507898C Immunoglobulin variants and uses thereof
02/18/2014CA2503442C Methods of diagnosing ischemia using eif-5a
02/18/2014CA2496317C Method of producing hydroxyalkyl starch derivatives
02/18/2014CA2454756C Methods and compounds for the targeting of protein to exosomes
02/18/2014CA2451741C Peyers's patch and/or m-celle targeting ligands
02/18/2014CA2413450C Streptococcus antigens
02/18/2014CA2403313C Potent t cell modulating molecules
02/18/2014CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
02/13/2014WO2014025890A1 Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids
02/13/2014WO2014025203A1 Water-soluble mannanase composition, and method for preparing same
02/13/2014WO2014025137A1 Uip1 gene for increasing resistance of plants to drought stress and use thereof
02/13/2014WO2014024965A1 Antigen peptide originated from t790m point-mutated sequence of epidermal growth factor receptor
02/13/2014WO2014024914A1 Peptide library and use thereof
02/13/2014WO2014024853A1 Pivka-ii measurement method, measurement reagent, and measurement kit
02/13/2014WO2014024820A1 Pharmaceutical composition for treating new chronic kidney disease and method for screening medicine for new chronic kidney disease
02/13/2014WO2014024194A1 Methods of growing aphid lethal paralysis virus (alpv) strains and uses thereof as insecticides
02/13/2014WO2014023852A1 Biomarkers
02/13/2014WO2014023827A1 Novel far red fluorescent protein
02/13/2014WO2014023752A1 Interleukin-2 fusion proteins and uses thereof
02/13/2014WO2014023673A1 Interleukin-10 fusion proteins and uses thereof
02/13/2014WO2014023672A1 Transgenic animal
02/13/2014WO2014023315A1 Multimerization through beta-strand swapping in ccp domains
02/13/2014WO2014023129A1 α-CONOTOXIN PEPTIDE, AND MEDICAL COMPOSITION AND PURPOSE THEREOF
02/13/2014WO2014023007A1 Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
02/13/2014WO2014022947A1 Short polypeptide inhibiting hiv and pharmacal use
02/13/2014WO2013186563A3 Factor viii sequences
02/13/2014WO2013186545A3 Chaperone/usher fusion proteins
02/13/2014WO2013181438A3 Compositions and methods for modulating pro-inflammatory immune response
02/13/2014WO2013080147A3 Anticancer fusion protein
02/13/2014WO2013040142A3 Bioinformatic processes for determination of peptide binding
02/13/2014US20140046049 Axmi-205 pesticidal gene and method for its use
02/13/2014US20140046035 Improved production of anti-peptide antibodies
02/13/2014US20140046028 Method for preparing a concentrate of factor xi
02/13/2014US20140046026 Superagonists and antagonists of interleukin-2
02/13/2014US20140046025 Device and method for production and analysis of prions
02/13/2014US20140045914 Recombinant protein for sirna delivery and composition comprising the same
02/13/2014US20140045775 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
02/13/2014US20140045764 Neuroprotective peptides
02/13/2014US20140045760 Neurotoxins exhibiting shortened biological activity
02/13/2014US20140045759 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
02/13/2014US20140045757 Compositions having antiangiogenic activity and uses thereof
02/13/2014US20140045756 Methods and compositions for modulating tnf/tnfr signaling
02/13/2014US20140045751 Recombinant human fibroblast growth factor-1 as a novel therapeutic for ischemic diseases and methods thereof
02/13/2014US20140045749 Growth factor complex
02/13/2014US20140045743 Compositions and methods for coronavirus inhibition
02/13/2014US20140045742 Serpin-finger fusion polypeptide
02/13/2014US20140045247 Fusion protein
02/13/2014US20140045216 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
02/13/2014US20140045214 Mutant microorganism belonging to the genus trichoderma and method for producing protein using the same
02/13/2014US20140045211 High level production of recombinant proteins
02/13/2014US20140044948 High-strength collagen fiber membrane and a manufacturing method thereof
02/13/2014US20140044775 Synthetic lung surfactant and use thereof
02/13/2014US20140044746 Monomeric and multimeric immunogenic peptides
02/13/2014US20140044745 Influenza A Virus Vaccines and Inhibitors
02/13/2014US20140044744 Novel hypoallergens
02/13/2014US20140044737 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
02/13/2014US20140044713 Compounds
02/13/2014US20140044680 Simian Subfamily B Adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and Uses Thereof
02/13/2014US20140044676 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
02/13/2014US20140044675 Interleukin-2 fusion proteins and uses thereof
02/13/2014US20140044674 Interleukin-10 fusion proteins and uses thereof
02/13/2014US20140044672 Conjugates of a gm-csf moiety and a polymer
02/13/2014DE102011118371B4 Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung For human vaccination suitable composition comprising a diphtheria toxoid, as well as processes for their preparation
02/13/2014CA2876285A1 Interleukin-10 fusion proteins and uses thereof
02/13/2014CA2874985A1 Fungal resistant plants expressing hcp5
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 2916